Newsfeeds - Spark Newswire

2 minute read

Celularity And Oncternal Therapeutics Enter Into Research Collaboration To Evaluate Targeted Placental-Derived Cellular Therapies

Today, 1:13 PM

Celularity Inc. (“Celularity”) (NASDAQ:CELU), a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic therapies, and Oncternal Therapeutics, Inc. (“Oncternal”)

CELU

2 minute read

Earnings

Return on Capital Employed Overview: Oncternal Therapeutics

By Benzinga Insights

Today, 1:13 PM

Benzinga Pro data, Oncternal Therapeutics (NASDAQ:ONCT) reported Q2 sales of $883.00 thousand. Earnings fell to a loss of $7.69 million, resulting in a 29.05% decrease from last quarter.

ONCT

2 minute read

Movers

Analyzing Oncternal Therapeutics’s Unusual Options Activity

By Benzinga Insights

Today, 1:13 PM

On Friday, shares of Oncternal Therapeutics (NASDAQ:ONCT) saw unusual options activity. After the option alert, the stock price moved up to $4.21.

ONCT

1 minute read

Earnings

Recap: Oncternal Therapeutics Q2 Earnings

By Benzinga Insights

Today, 1:13 PM

Shares of Oncternal Therapeutics (NASDAQ:ONCT) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 52.94% over the past year to ($0.16), which missed the estimate of ($0.14).

ONCT

1 minute read

Oncternal Therapeutics Q2 EPS $(0.16) Misses $(0.14) Estimate, Sales $883.00K Miss $1.09M Estimate

By Benzinga Newsdesk

Today, 1:13 PM

Oncternal Therapeutics (NASDAQ:ONCT) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 52.94 percent increase over losses of $(0.34) per

ONCT

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 1:13 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 1:13 PM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

6 minute read

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

By Shanthi Rexaline

Today, 1:13 PM

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.

ABUS

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 1:13 PM

ARPO

2 minute read

Uncategorized

Pharma/Biotech Companies Highlight Upcoming Presentations At American Society Of Clinical Oncology Jun. 4-8, 2021

By Benzinga Newsdesk

Today, 1:13 PM

Cullinan Oncology (CGEM) - https://www.globenewswire.com/news-release/2021/05/19/2232874/0/en/Cullinan-Oncology-to-Provide-CLN-081-Clinical-Update-at-ASCO-2021.html BeiGene (BGNE)

ADAP